The HTBS will therefore appraise and evaluate a number of new drugs each year as part of its wider remit.When a new drug is marketed, the local Area Drug and Therapeutics Committees (ADTCs) have the role of providing advice to prescribers and health boards about whether or not the new medicine (or new therapeutic indication) should be adopted into practice.